Biotechnology News

Glioblastoma Research

Dynamic42's BBB-on-chip model is being used to study glioblastoma treatment, with a focus on the blood-brain barrier.

Transfer Learning’s Quiet Promise for Drug Manufacturing

Pfizer’s 2021 AI-driven process optimization pilot cut small-molecule development time by 20%, yet similar gains for biologics remain unproven.

Tumors Sabotage Immune Cells—Can Mitochondria Fix It?

Mouse studies now show tumors disable dendritic cells by crippling their mitochondria—a vulnerability that may explain immunotherapy resistance in 30–40% of patients.

Blood Test Detects Cancer

Researchers have developed a blood test that analyzes cell-free DNA to detect multiple cancers, liver conditions, and organ abnormalities.

Text Mining Unlocks Glycosylation Insights for Biopharma

A new text-mining method could cut bioprocess trial-and-error—but only if it survives real-world validation.

Inflammation’s Epigenetic Scars May Linger, Raising Colon Cancer Risk

New research in *Genetic Engineering & Biotechnology News* reveals how epigenetic alterations from gut inflammation endure long after healing, potentially setting the stage for colon cancer.

How Parasites Rewire Gut-Brain Signals to Curb Appetite

When parasitic worms invade the gut, the body’s response goes beyond local inflammation.

Xaira Unveils X-Cell

Xaira's X-Cell model is the largest virtual cell model to-date, with 1 million parameters, according to the company's press release.

Genomic Mapping Identifies High-Risk E. coli for Vaccines

Engineered Immune Cells Target Solid Tumors via Metabolites

Scarless Skin Healing in Mice—But What About Humans?

For decades, the dream of scarless wound healing has hovered just beyond reach—until now.

In-Vivo CAR T Cell Breakthrough—But How Far From Patients?

Lab-grown CAR T cells bypass external editing—preclinical success against 3 cancers, a major leap for solid tumors.